• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The paradox of the evidence about invasive fungal infection prevention.

作者信息

Cortegiani Andrea, Russotto Vincenzo, Raineri Santi Maurizio, Giarratano Antonino

机构信息

Department of Biopathology and Medical Biotechnologies (DIBIMED), Section of Anesthesia, Analgesia, Intensive Care and Emergency, Policlinico P. Giaccone, University of Palermo, Via del Vespro 129, 90127, Palermo, Italy.

出版信息

Crit Care. 2016 Apr 27;20(1):114. doi: 10.1186/s13054-016-1284-7.

DOI:10.1186/s13054-016-1284-7
PMID:27117474
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4847266/
Abstract
摘要

相似文献

1
The paradox of the evidence about invasive fungal infection prevention.侵袭性真菌感染预防证据的悖论。
Crit Care. 2016 Apr 27;20(1):114. doi: 10.1186/s13054-016-1284-7.
2
Tolerability and outcome of once weekly liposomal amphotericin B for the prevention of invasive fungal infections in hematopoietic stem cell transplant patients with graft-versus-host disease.每周一次脂质体两性霉素B预防造血干细胞移植伴移植物抗宿主病患者侵袭性真菌感染的耐受性及疗效
J Oncol Pharm Pract. 2016 Apr;22(2):228-34. doi: 10.1177/1078155214560920. Epub 2014 Dec 3.
3
Safety and efficacy of treatment with liposomal amphotericin B in elderly patients at least 65 years old with hematological diseases.脂质体两性霉素B治疗65岁及以上老年血液病患者的安全性和有效性。
J Infect Chemother. 2016 May;22(5):287-91. doi: 10.1016/j.jiac.2016.01.009. Epub 2016 Feb 19.
4
The issue of the antifungal drug choice in prophylaxis of invasive fungal infection after liver transplant.肝移植术后侵袭性真菌感染预防中抗真菌药物的选择问题。
Transpl Infect Dis. 2020 Feb;22(1):e13220. doi: 10.1111/tid.13220. Epub 2019 Dec 12.
5
Executive Summary of Japanese Domestic Guidelines for Management of Deep-seated Mycosis 2014.《2014年日本深部真菌病管理国内指南执行摘要》
Med Mycol J. 2016;57(4):E117-E163. doi: 10.3314/mmj.16-00010.
6
Standards of CARE: what is considered 'best practice' for the management of invasive fungal infections? A haematologist's and a mycologist's perspective.CARE 标准：侵袭性真菌感染管理的“最佳实践”是什么？血液学家和真菌学家的观点。
J Antimicrob Chemother. 2019 Mar 1;74(Suppl 2):ii3-ii8. doi: 10.1093/jac/dkz037.
7
[Noticeable questions on diagnosis and treatment of invasive fungal infection].[侵袭性真菌感染诊断与治疗中的显著问题]
Zhonghua Nei Ke Za Zhi. 2019 Aug 1;58(8):553-555. doi: 10.3760/cma.j.issn.0578-1426.2019.08.001.
8
Both "Small Ball" and "Big Inning" Teams Are Progressing the Value of Antifungal Prophylaxis Among Patients With Hematologic Malignancy.“小球战术”和“大得分局”团队都在提升血液系统恶性肿瘤患者抗真菌预防的价值。
Clin Infect Dis. 2021 May 18;72(10):1764-1766. doi: 10.1093/cid/ciaa569.
9
Is preemptive antifungal therapy a good alternative to empirical treatment in prolonged febrile neutropenia?在长期发热性中性粒细胞减少症中，抢先抗真菌治疗是经验性治疗的一个好的替代方案吗？
Medwave. 2016 Jun 9;16 Suppl 2:e6463. doi: 10.5867/medwave.2016.6463.
10
[A new hope to fight invasive fungal infection].对抗侵袭性真菌感染的新希望
Med Sci (Paris). 2018 Feb;34(2):123-125. doi: 10.1051/medsci/20183402007. Epub 2018 Feb 16.

引用本文的文献

1
Survival Outcome of Empirical Antifungal Therapy and the Value of Early Initiation: A Review of the Last Decade.经验性抗真菌治疗的生存结果及早期开始治疗的价值：过去十年综述
J Fungi (Basel). 2022 Oct 29;8(11):1146. doi: 10.3390/jof8111146.
2
Effect of empirical antifungal treatment on mortality in non-neutropenic critically ill patients: a propensity-matched retrospective cohort study.经验性抗真菌治疗对非中性粒细胞减少危重症患者死亡率的影响：一项倾向评分匹配的回顾性队列研究。
Eur J Clin Microbiol Infect Dis. 2022 Dec;41(12):1421-1432. doi: 10.1007/s10096-022-04507-3. Epub 2022 Oct 18.
3
Procalcitonin levels in candidemia versus bacteremia: a systematic review.降钙素原水平在念珠菌血症与菌血症中的比较：一项系统综述。
Crit Care. 2019 May 28;23(1):190. doi: 10.1186/s13054-019-2481-y.
4
Untargeted antifungal therapy in adult patients with complicated intra-abdominal infection: protocol for a systematic review with meta-analysis.成人复杂性腹腔内感染患者的非靶向抗真菌治疗：一项系统评价与荟萃分析的方案
BMJ Open. 2017 May 29;7(5):e015900. doi: 10.1136/bmjopen-2017-015900.
5
Lessons from uncertainty on antifungal treatment in ICU.重症监护病房抗真菌治疗不确定性的经验教训。
J Thorac Dis. 2017 Apr;9(4):E390-E391. doi: 10.21037/jtd.2017.03.65.
6
Dying with or Because of Invasive Fungal Infection? The Role of Immunity Exhaustion on Patient Outcome.死于侵袭性真菌感染还是因侵袭性真菌感染而死？免疫耗竭对患者预后的作用。
Turk J Anaesthesiol Reanim. 2016 Dec;44(6):285-286. doi: 10.5152/TJAR.2016.0013. Epub 2016 Dec 1.
7
Antifungal Treatment Strategies in the ICU: Beyond Meta-analysis.重症监护病房中的抗真菌治疗策略：超越荟萃分析
Turk J Anaesthesiol Reanim. 2016 Dec;44(6):283-284. doi: 10.5152/TJAR.2016.0012. Epub 2016 Dec 1.
8
Appropriate Treatment of Invasive Candidiasis in ICU: Timing, Colonization Index, Candida Score & Biomarkers, Towards de-Escalation?重症监护病房侵袭性念珠菌病的恰当治疗：时机、定植指数、念珠菌评分及生物标志物，走向降阶梯治疗？
Turk J Anaesthesiol Reanim. 2016 Dec;44(6):279-282. doi: 10.5152/TJAR.2016.0011. Epub 2016 Dec 1.
9
Should we Administer Antifungal Drugs Before the Diagnosis of Invasive Fungal Infection in Non-Neutropenic Critically Ill Patients?对于非中性粒细胞减少的重症患者，我们是否应在侵袭性真菌感染诊断之前给予抗真菌药物？
Turk J Anaesthesiol Reanim. 2016 Dec;44(6):276-278. doi: 10.5152/TJAR.2016.0010. Epub 2016 Dec 1.
10
Should we continue to use prediction tools to identify patients at risk of Candida spp. infection? If yes, why?我们是否应该继续使用预测工具来识别念珠菌属感染风险的患者？如果是，为什么？
Crit Care. 2016 Oct 30;20(1):351. doi: 10.1186/s13054-016-1521-0.

本文引用的文献

1
T cells from patients with Candida sepsis display a suppressive immunophenotype.念珠菌败血症患者的T细胞表现出抑制性免疫表型。
Crit Care. 2016 Jan 20;20:15. doi: 10.1186/s13054-016-1182-z.
2
Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.用于预防非中性粒细胞减少的重症患者真菌感染的抗真菌药物。
Cochrane Database Syst Rev. 2016 Jan 16;2016(1):CD004920. doi: 10.1002/14651858.CD004920.pub3.
3
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.《念珠菌病管理临床实践指南：美国传染病学会2016年更新版》
Clin Infect Dis. 2016 Feb 15;62(4):e1-50. doi: 10.1093/cid/civ933. Epub 2015 Dec 16.
4
A randomized, placebo-controlled trial of preemptive antifungal therapy for the prevention of invasive candidiasis following gastrointestinal surgery for intra-abdominal infections.一项关于预防性抗真菌治疗以预防腹部感染性疾病胃肠道手术后侵袭性念珠菌病的随机、安慰剂对照试验。
Clin Infect Dis. 2015 Dec 1;61(11):1671-8. doi: 10.1093/cid/civ707. Epub 2015 Aug 13.
5
Impact of therapeutic strategies on the prognosis of candidemia in the ICU.ICU 中不同治疗策略对念珠菌血症预后的影响。
Crit Care Med. 2014 Jun;42(6):1423-32. doi: 10.1097/CCM.0000000000000221.
6
MSG-01: A randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting.MSG-01 号研究：一项在重症监护环境中对高危成人进行的随机、双盲、安慰剂对照的卡泊芬净预防治疗后进行抢先治疗侵袭性念珠菌病的试验。
Clin Infect Dis. 2014 May;58(9):1219-26. doi: 10.1093/cid/ciu074. Epub 2014 Feb 18.
7
EMPIRICUS micafungin versus placebo during nosocomial sepsis in Candida multi-colonized ICU patients with multiple organ failures: study protocol for a randomized controlled trial.经验性米卡芬净与安慰剂在 ICU 多器官衰竭合并念珠菌定植的院内脓毒症患者中的比较：一项随机对照试验的研究方案。
Trials. 2013 Nov 21;14:399. doi: 10.1186/1745-6215-14-399.
8
Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain.西班牙基于人群的监测：念珠菌血流感染的早期和晚期死亡率的流行病学和预测因素。
Clin Microbiol Infect. 2014 Apr;20(4):O245-54. doi: 10.1111/1469-0691.12380. Epub 2013 Oct 11.
9
Pre-emptive treatment of fungal infection based on plasma β-D-glucan levels after gastric surgery for gastric cancer in elderly patients.老年胃癌患者胃手术后基于血浆 1,3-β-D-葡聚糖水平的真菌抢先治疗。
J Gastroenterol Hepatol. 2013 Sep;28(9):1457-61. doi: 10.1111/jgh.12219.
10
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.ESCMID*指南：2012 年念珠菌病的诊断和管理：非中性粒细胞减少成年患者。
Clin Microbiol Infect. 2012 Dec;18 Suppl 7:19-37. doi: 10.1111/1469-0691.12039.